$HCIL
Hongchang International Co., Ltd

2024 Q3 Form 10-Q Financial Statement

#000121390024068246 Filed on August 13, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2 2023 Q4
Revenue $820.6K $1.982M
YoY Change 1496.61%
Cost Of Revenue $770.5K $1.883M
YoY Change 1123.85% 62443.44%
Gross Profit $50.14K $98.72K
YoY Change -533.78% -3378.48%
Gross Profit Margin 6.11% 4.98%
Selling, General & Admin $102.8K $122.7K
YoY Change
% of Gross Profit 205.09% 124.33%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $102.8K $122.7K
YoY Change -25.05% -16.11%
Operating Profit -$52.69K -$24.01K
YoY Change -64.58% -83.92%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$9.00
YoY Change -1000.0%
Pretax Income -$50.19K -$22.41K
YoY Change -64.32% -83.8%
Income Tax -$5.421K -$733.00
% Of Pretax Income
Net Earnings -$61.06K -$64.80K
YoY Change -57.74% -53.17%
Net Earnings / Revenue -7.44% -3.27%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 518.8M shares 518.8M shares 518.8M shares
Diluted Shares Outstanding 518.8M shares 518.8M shares

Balance Sheet

Concept 2024 Q3 2024 Q2 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $307.0K $317.4K $895.7K
Short-Term Investments
Other Short-Term Assets $1.062M $969.2K $1.142M
YoY Change 24.99% 36398.69%
Inventory $1.855M $1.781M $13.71K
Prepaid Expenses $23.32K
Receivables $291.3K $1.034M $742.9K
Other Receivables $57.85K $6.977K $1.107M
Total Short-Term Assets $4.372M $5.050M $3.961M
YoY Change 56.63% 15461.01% 12123.0%
LONG-TERM ASSETS
Property, Plant & Equipment $19.31K $15.75K $3.193K
YoY Change
Goodwill
YoY Change
Intangibles $2.993K $2.969K $3.213K
YoY Change
Long-Term Investments
YoY Change
Other Assets $9.493M $4.903M $706.9K
YoY Change 430.65% 21691.89%
Total Long-Term Assets $57.74M $51.17M $46.25M
YoY Change 29.78% 26663.69%
TOTAL ASSETS
Total Short-Term Assets $4.372M $5.050M $3.961M
Total Long-Term Assets $57.74M $51.17M $46.25M
Total Assets $62.11M $56.22M $50.22M
YoY Change 31.37% 25038.04% 154867.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $119.8K $119.4K $385.8K
YoY Change 58.58% -5.34% 35.33%
Deferred Revenue $29.54K
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due $38.50K
YoY Change
Total Short-Term Liabilities $542.4K $866.5K $1.055M
YoY Change -93.24% -63.51% -47.37%
LONG-TERM LIABILITIES
Long-Term Debt $6.449M
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $20.86M $16.05M $8.672M
YoY Change 17226.44%
TOTAL LIABILITIES
Total Short-Term Liabilities $542.4K $866.5K $1.055M
Total Long-Term Liabilities $20.86M $16.05M $8.672M
Total Liabilities $21.40M $16.92M $9.728M
YoY Change 166.72% 585.66% 385.17%
SHAREHOLDERS EQUITY
Retained Earnings -$1.035M -$973.9K -$812.5K
YoY Change 25.27% -95.19% -95.91%
Common Stock $40.42M $40.42M $518.8K
YoY Change 7691.37% 39052.77% -49.75%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $40.65M $39.26M $40.49M
YoY Change
Total Liabilities & Shareholders Equity $62.11M $56.22M $50.22M
YoY Change 31.37% 25038.04% 154867.19%

Cashflow Statement

Concept 2024 Q3 2024 Q2 2023 Q4
OPERATING ACTIVITIES
Net Income -$61.06K -$64.80K
YoY Change -57.74% -53.17%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
usd
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
518831367 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
518831367 shares
dei Security Exchange Name
SecurityExchangeName
NONE
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
usd
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
415582375 shares
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4903175 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
706920 usd
CY2024Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
51168437 usd
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
46254826 usd
CY2024Q2 us-gaap Assets
Assets
56218451 usd
CY2023Q4 us-gaap Assets
Assets
50215568 usd
CY2024Q2 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
151470 usd
CY2023Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
650905 usd
CY2024Q2 us-gaap Construction Payable Current
ConstructionPayableCurrent
15672 usd
CY2023Q4 us-gaap Construction Payable Current
ConstructionPayableCurrent
18493 usd
CY2024Q2 hcil Advances From Customers
AdvancesFromCustomers
161225 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
119429 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
385805 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
866454 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1055203 usd
CY2024Q2 hcil Deferred Subsidies
DeferredSubsidies
1938094 usd
CY2023Q4 hcil Deferred Subsidies
DeferredSubsidies
1989463 usd
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
5916793 usd
CY2024Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
16051390 usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
8672422 usd
CY2024Q2 us-gaap Liabilities
Liabilities
16917844 usd
CY2023Q4 us-gaap Liabilities
Liabilities
9727625 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2000000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2000000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
518831367 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
518831367 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
518831367 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
518831367 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
518831 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
518831 usd
CY2024Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
39905228 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
39905228 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-973915 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-812539 usd
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-192263 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
876423 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
39257881 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
40487943 usd
CY2024Q2 us-gaap Minority Interest
MinorityInterest
42726 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
39300607 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
40487943 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
56218451 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
50215568 usd
CY2024Q2 us-gaap Revenues
Revenues
1981898 usd
us-gaap Revenues
Revenues
2000102 usd
us-gaap Revenues
Revenues
26807 usd
CY2024Q2 us-gaap Cost Of Revenue
CostOfRevenue
1883183 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
3011 usd
us-gaap Cost Of Revenue
CostOfRevenue
1901660 usd
us-gaap Cost Of Revenue
CostOfRevenue
41475 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
98715 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
-3011 usd
us-gaap Gross Profit
GrossProfit
98442 usd
us-gaap Gross Profit
GrossProfit
-14668 usd
CY2024Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
155 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
191 usd
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
122574 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
146300 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
224574 usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-26731
dei Entity Registrant Name
EntityRegistrantName
Hongchang International Co., Ltd
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-0627910
dei Entity Address Address Line1
EntityAddressAddressLine1
Block 20
dei Entity Address Address Line2
EntityAddressAddressLine2
Hongchang Food Co., Ltd., Yuanhong Investment Zone
dei Entity Address Address Line3
EntityAddressAddressLine3
Donggao Village
dei Entity Address City Or Town
EntityAddressCityOrTown
Fuzhou City
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
350300
dei Entity Address Country
EntityAddressCountry
CN
dei City Area Code
CityAreaCode
(86)
dei Local Phone Number
LocalPhoneNumber
180 5901 6050
dei Security12b Title
Security12bTitle
None
dei Trading Symbol
TradingSymbol
None
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
518831367 shares
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
317374 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
895730 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1033707 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
742851 usd
CY2024Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
6977 usd
CY2023Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
1106574 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
1780691 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
13713 usd
CY2024Q2 us-gaap Supplies
Supplies
942056 usd
CY2023Q4 us-gaap Supplies
Supplies
13811 usd
CY2024Q2 us-gaap Other Assets Current
OtherAssetsCurrent
969209 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1128598 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
5050014 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
3960742 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15752 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3193 usd
CY2024Q2 hcil Constructioninprogress
Constructioninprogress
42277536 usd
CY2023Q4 hcil Constructioninprogress
Constructioninprogress
41423399 usd
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2969 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3213 usd
CY2024Q2 hcil Land Use Right Net
LandUseRightNet
3969005 usd
CY2023Q4 hcil Land Use Right Net
LandUseRightNet
4118101 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
244386 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
122729 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
146300 usd
us-gaap Operating Expenses
OperatingExpenses
224765 usd
us-gaap Operating Expenses
OperatingExpenses
244386 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-24014 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-149311 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-126323 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-259054 usd
CY2024Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
445 usd
CY2023Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
267 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
905 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
471 usd
CY2024Q2 us-gaap Other Income
OtherIncome
1155 usd
CY2023Q2 us-gaap Other Income
OtherIncome
10679 usd
us-gaap Other Income
OtherIncome
1156 usd
us-gaap Other Income
OtherIncome
10679 usd
CY2024Q2 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
-1 usd
CY2023Q2 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
16 usd
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
146 usd
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
38 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-22413 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-138381 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-124408 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-247942 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-733 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-6159 usd
CY2024Q2 us-gaap Profit Loss
ProfitLoss
-21680 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-138381 usd
us-gaap Profit Loss
ProfitLoss
-118249 usd
us-gaap Profit Loss
ProfitLoss
-247942 usd
CY2024Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
43124 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
43124 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-64804 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-138381 usd
us-gaap Net Income Loss
NetIncomeLoss
-161373 usd
us-gaap Net Income Loss
NetIncomeLoss
-247942 usd
CY2024Q2 us-gaap Profit Loss
ProfitLoss
-21680 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-138381 usd
us-gaap Profit Loss
ProfitLoss
-118249 usd
us-gaap Profit Loss
ProfitLoss
-247942 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-253677 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2032617 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1069087 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
107001 usd
CY2024Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-275357 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-2170998 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-1187336 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-140941 usd
CY2024Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
42726 usd
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
42726 usd
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-318083 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2170998 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1230062 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-140941 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
518831367 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
428355467 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
518831367 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
428355467 shares
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
40487943 usd
us-gaap Profit Loss
ProfitLoss
-118249 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-1069087 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
39300607 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-418653 usd
us-gaap Profit Loss
ProfitLoss
-247942 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
29153 usd
hcil Contribution From Shareholder
ContributionFromShareholder
41241108 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
40603666 usd
us-gaap Profit Loss
ProfitLoss
-118249 usd
us-gaap Profit Loss
ProfitLoss
-247942 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
43879 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
37369 usd
hcil Accrued Interest Income Derived From Loan To Third Party
AccruedInterestIncomeDerivedFromLoanToThirdParty
10390 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-10791 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
312923 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
12309 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1783784 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
26749 usd
us-gaap Increase Decrease In Prepaid Supplies
IncreaseDecreaseInPrepaidSupplies
937246 usd
hcil Increase Decrease Advance From Customer
IncreaseDecreaseAdvanceFromCustomer
-58330 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
2898 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-142251 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
867382 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-487123 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
16011 usd
us-gaap Increase Decrease In Notes Payable Related Parties
IncreaseDecreaseInNotesPayableRelatedParties
422555 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-261937 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
1151 usd
us-gaap Increase Decrease In Customer Advances
IncreaseDecreaseInCustomerAdvances
162726 usd
hcil Increase Decrease Deferred Subsidies
IncreaseDecreaseDeferredSubsidies
2032732 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3085210 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
922491 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6211043 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
40627234 usd
us-gaap Proceeds From Payments For Long Term Loans For Related Parties
ProceedsFromPaymentsForLongTermLoansForRelatedParties
139 usd
hcil Repayments From A Third Party Investing
RepaymentsFromAThirdPartyInvesting
-1083893 usd
hcil Payments Of Loan To Third Party
PaymentsOfLoanToThirdParty
1030437 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5127011 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-41657671 usd
us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
41241108 usd
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
5971873 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
1755467 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
2695155 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
3435416 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1331757 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7651822 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
39877710 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-17957 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1728475 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-578356 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
871005 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
895730 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3141 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
317374 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
874146 usd
us-gaap Interest Paid
InterestPaid
127657 usd
us-gaap Interest Paid Net
InterestPaidNet
135109 usd
hcil Increased Accounts Payableconstruction In Progress For Constructioninprogress
IncreasedAccountsPayableconstructionInProgressForConstructioninprogress
2365 usd
us-gaap Nature Of Operations
NatureOfOperations
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>1. ORGANIZATION</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><b><i>(a) Nature of operations</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Hongchang International Co., Ltd (the “Company”) was incorporated in the state of Nevada on May 18, 1987. The Company is a holding company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On September 4, 2023, Heyu Biological Technology Corporation (“HYBT”), the Company’s predecessor, completed the merger and other related transactions (the “Merger Transactions”) with Hongchang Global Investment Holdings Limited (“Hongchang BVI”), as a result of which Hongchang BVI became a wholly-owned subsidiary of HYBT and HYBT assumed and began conducting the principal business of Hongchang BVI. The name of the Company was changed from “Heyu Biological Technology Corporation” to “Hongchang International Co., Ltd.” (HCIL).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The “Group” means (i) prior to the completion of the Reorganization, Hongchang BVI and its subsidiaries that engage in businesses of food trade and biotechnology in China (ii) upon and after completion of the Merger Transactions, the Company and its subsidiaries that engage in businesses of food trade and meat processing in China.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><b><i>(b) History and reorganization of the Group</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In preparation of the Merger Transactions, the following transactions were undertaken to reorganize the legal structure of Operating Entity (“Reorganization”). On January 13, 2023, Mr. Zengqiang Lin and Ms. Zhenzhu Lin, the existing stockholders of Fuqing Hongchang Food Co., Ltd (“Hongchang Food”) established two wholly-owned subsidiaries (“BVI-1” and “BVI-2”) in British Virgin Island, respectively. On January 18, 2023, Hong Chang Global Investment Holdings Limited (“Hongchang BVI”) was then incorporated by BVI-1 and BVI-2 which held 70% and 30% equity interest of Hongchang BVI, respectively. On February 6, 2023, Hongchang BVI incorporated a wholly-owned subsidiary, Hong Chang Biotechnologies (HK) Limited (“Hongchang HK”). On February 28, 2023, Hongchang HK incorporated a wholly-owned subsidiary, Fujian Hongjin Biotechnology Co., Ltd. (“WFOE”) in the People’s Republic of China (“PRC”). WFOE then purchased the total equity interest of Hongchang Food. After the Reorganization, Mr. Zengqiang Lin and Ms. Zhenzhu Lin hold 70% and 30% equity interest of Hongchang Food through WFOE, respectively. As all the entities involved in the process of the Reorganization are under common ownership of Hongchang Food’s stockholders before and after the Reorganization, the Reorganization is accounted for in a manner similar to a pooling of interests with the assets and liabilities of the parties to the Reorganization carried over at their historical amounts. Therefore, the accompanying unaudited condensed consolidated financial statements were prepared as if the corporate structure of the Group had been in existence since the beginning of the periods presented.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>(c) Reverse merger</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August 21, 2023, HYBT entered into a Share Exchange Agreement (the “Share Exchange Agreement”) with Hongchang BVI and Hongchang BVI’s stockholders, Zengqiang Investment Limited, a business company incorporated in the BVI, and Hong Jin Investment Limited, a business company incorporated in the BVI (the “Selling Stockholders” and each a “Selling Stockholder”), in relation to the acquisition of Hongchang BVI by HYBT (the “Hongchang Acquisition”). Zengqiang Investment Limited is wholly-owned by Mr. Zengqiang Lin and Hong Jin Investment Limited is wholly-owned by Ms. Zhenzhu Lin. Mr. Zengqiang Lin has been a director of HYBT since February 17, 2023, and Ms. Zhenzhu Lin is the sister of Mr. Zengqiang Lin. In accordance with the terms of the Share Exchange Agreement, the Selling Stockholders sold and transferred 100 shares of Hongchang BVI, constituting all of the issued and outstanding share capital of Hongchang BVI, to HYBT in exchange for an aggregate of 415,582,375 new shares of HYBT’s common stock (the “Consideration Shares”), of which 353,322,843 shares were issued to Zengqiang Investment Limited and 62,259,532 shares were issued to Hong Jin Investment Limited.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Immediately following the closing of the Hongchang Acquisition, HYBT had a total of 518,831,367 issued and outstanding shares of common stock. The 415,582,375 Consideration Shares constitute 80.1% of its enlarged share capital following the closing of the Hongchang Acquisition. The exchange consideration for the Hongchang Acquisition was determined on an arms’ length basis based on our valuation of Hongchang BVI and its subsidiaries and its assets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As HYBT, the legal acquirer and accounting acquiree, does not meet the definition of a business, management concluded that the Merger should be accounted for as a continuation of the financial statements of Hongchang BVI (the legal subsidiary), together with a deemed issue of shares and a re-capitalization of the equity of Hongchang BVI. Hongchang BVI is the continuing entity and is deemed to have issued shares in exchange for the identifiable net assets held by HYBT together with the listing status of HYBT. Management concluded that September 4, 2023 is the acquisition date of the Merger.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Upon the completion of the reverse merger, the Company has set up a few new subsidiaries: Fujian Hongchang Global Food Co., Ltd (“Hongchang Global Food”), Fuqing Hongchang Global Import &amp; Export Co., Ltd (“Hongchang Import &amp; Export”), Fuqing Hongchang Global Supply Chain Co., Ltd (“Hongchang Supply Chain”), and Hongchang Global (Fuqing City) Agricultural Technology Development Co., Ltd (“Hongchang Agricultural”) in order for the company to develop different businesses. As of the date of this report, these subsidiaries have not generated significant revenue.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In May 2024, the Company set up a new subsidiary Hongfu Food (Fujian) Co., Ltd (“Hongfu Food”), which is mainly engaged in the initial processing of agricultural products, specializing in pork segmentation and trade. Hongfu Food purchasing pork as raw materials and processing or dividing them into various finished products according to customer needs, or through secondary segmentation into various specifications of packed finished products.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Based on above transactions, the accompanying unaudited condensed consolidated financial statements reflect the activities of each of the following entities:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; border-bottom: black 1.5pt solid; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Entity</b></span></td> <td style="white-space: nowrap; text-align: center"> </td> <td style="white-space: nowrap; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Place of <br/> incorporation</b></span></td> <td style="white-space: nowrap; text-align: center"> </td> <td style="white-space: nowrap; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage of <br/> direct or <br/> indirect <br/> ownership <br/> by the <br/> Company</b></span></td> <td style="white-space: nowrap; text-align: center"> </td> <td style="white-space: nowrap; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Principal activities</b></span></td></tr> <tr> <td style="vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Subsidiaries:</span></span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center"> </td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: top; width: 44%; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hong Chang Global Investment Holdings Limited (Hongchang BVI)</span></td> <td style="vertical-align: bottom; width: 1%"> </td> <td style="vertical-align: top; width: 15%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">British Virgin Island</span></td> <td style="vertical-align: bottom; width: 1%"> </td> <td style="vertical-align: top; width: 8%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</span></td> <td style="vertical-align: bottom; width: 1%"> </td> <td style="vertical-align: top; width: 30%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment holding</span></td></tr> <tr> <td style="vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hong Chang Biotechnologies (HK) Limited (Hongchang HK)</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hong Kong</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment holding</span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fujian Hongjin Biotechnology Co., Ltd.(WFOE)</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRC</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provision of technical and consultation services</span></td></tr> <tr> <td style="vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fuqing Hongchang Food Co., Ltd(Hongchang Food)</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRC</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provision of Food Industry Park operation, food trade and meat processing</span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fujian Hongchang Global Food Co., Ltd (“Hongchang Global Food”)</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRC</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provision of food trade </span></td></tr> <tr> <td style="vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fuqing Hongchang Global Import &amp; Export Co., Ltd(“Hongchang Import&amp;Export”)</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRC</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provision of food trade </span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fuqing Hongchang Global Supply Chain Co., Ltd(“Hongchang Supply Chain”)</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRC</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provision of food trade</span></td></tr> <tr> <td style="vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hongchang Global (Fuqing City) Agricultural Technology Development Co., Ltd (“Hongchang Agricultural”)</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRC</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provision of food trade and biotechnology</span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hongfu Food (Fujian) Co., Ltd (“Hongfu Food”)</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRC</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">51%</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provision of food trade and meat processing</span></td></tr> </table>
CY2024Q2 hcil Percentage Of Share Capital
PercentageOfShareCapital
0.801 pure
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preparation of the unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, related disclosures of contingent assets and liabilities at the balance sheet date, and the reported revenue and expenses during the reported period in the unaudited condensed consolidated financial statements and accompanying notes. Significant accounting estimates reflected in the Group’s unaudited condensed consolidated financial statements mainly include, but are not limited to, assessment for impairment of long-lived assets, valuation of deferred tax assets and current expected credit loss of receivables.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Management bases the estimates on historical experience and on various other assumptions as discussed elsewhere to the unaudited condensed consolidated financial statements that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. On an ongoing basis, management evaluates its estimates based on information that is currently available. Changes in circumstances, facts and experience may cause the Group to revise its estimates. Changes in estimates are recorded in the period in which they become known. Actual results could materially differ from these estimates.</p>
CY2024Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
70000 usd
CY2024Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
500000 cny
us-gaap Insured Event Gain Loss
InsuredEventGainLoss
167400 usd
us-gaap Interest Paid Capitalized
InterestPaidCapitalized
135109 usd
CY2024Q2 hcil Deferred Subsidies Current
DeferredSubsidiesCurrent
1938094 usd
CY2023Q4 hcil Deferred Subsidies Current
DeferredSubsidiesCurrent
1989463 usd
CY2023Q2 hcil Capital Contribution
CapitalContribution
41241108 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 pure
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-973915 usd
us-gaap Profit Loss
ProfitLoss
-118249 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
41241108 usd
CY2023Q2 us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
60000000 cny
CY2023Q2 us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
8500000 usd
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Financial Statement Reclassification </i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Certain balances in the prior year consolidated financial statements have been reclassified for comparison purposes to conform to the presentation in the current year consolidated financial statements. These reclassifications had no effect on the reported results of operations or financial position.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p>
CY2024Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1033707 usd
CY2023Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
742851 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1033707 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
742851 usd
CY2023Q4 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
1079127 usd
CY2024Q2 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
6977 usd
CY2023Q4 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
27447 usd
CY2024Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
6977 usd
CY2023Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
1106574 usd
CY2023Q4 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
1079127 usd
CY2024Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
218885 usd
CY2024Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1561806 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
13713 usd
CY2024Q2 us-gaap Inventory Gross
InventoryGross
1780691 usd
CY2023Q4 us-gaap Inventory Gross
InventoryGross
13713 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
1780691 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
13713 usd
CY2024Q2 us-gaap Supplies
Supplies
942056 usd
CY2023Q4 us-gaap Supplies
Supplies
13811 usd
CY2023Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
59324 usd
CY2024Q2 hcil Advance To Supplier
AdvanceToSupplier
942056 usd
CY2023Q4 hcil Advance To Supplier
AdvanceToSupplier
73135 usd
CY2024Q2 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
894360 usd
CY2023Q4 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
1039421 usd
CY2024Q2 us-gaap Deferred Income Taxes And Other Assets Current
DeferredIncomeTaxesAndOtherAssetsCurrent
74849 usd
CY2023Q4 us-gaap Deferred Income Taxes And Other Assets Current
DeferredIncomeTaxesAndOtherAssetsCurrent
65858 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
23319 usd
CY2024Q2 us-gaap Other Assets Current
OtherAssetsCurrent
969209 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1128598 usd
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
16483 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3381 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
731 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
188 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15752 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3193 usd
us-gaap Depreciation
Depreciation
554 usd
us-gaap Depreciation
Depreciation
0 usd
CY2024Q2 us-gaap Construction In Progress Gross
ConstructionInProgressGross
42277536 usd
CY2023Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
41423399 usd
CY2024Q2 hcil Construction In Progress Net Total
ConstructionInProgressNetTotal
42277536 usd
CY2023Q4 hcil Construction In Progress Net Total
ConstructionInProgressNetTotal
41423399 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3210 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3295 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
241 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
82 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2969 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3213 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
162 usd
CY2024Q2 us-gaap Land
Land
4275487 usd
CY2023Q4 us-gaap Land
Land
4388808 usd
CY2024Q2 hcil Less Accumulated Amortization
LessAccumulatedAmortization
306482 usd
CY2023Q4 hcil Less Accumulated Amortization
LessAccumulatedAmortization
270707 usd
CY2024Q2 hcil Land Use Right Net
LandUseRightNet
3969005 usd
CY2023Q4 hcil Land Use Right Net
LandUseRightNet
4118101 usd
hcil Land Use Right Term
LandUseRightTerm
P50Y
CY2024Q2 hcil Advance Payment For Construction Gross
AdvancePaymentForConstructionGross
4900616 usd
CY2023Q4 hcil Advance Payment For Construction Gross
AdvancePaymentForConstructionGross
706920 usd
CY2024Q2 hcil Advance Payment For Equipment
AdvancePaymentForEquipment
2559 usd
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4903175 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
706920 usd
CY2024Q2 hcil Advance Payment For Construction
AdvancePaymentForConstruction
4900616 usd
CY2023Q4 hcil Advance Payment For Construction
AdvancePaymentForConstruction
706920 usd
CY2024Q2 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
97336 usd
CY2023Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
92262 usd
CY2024Q2 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
6385 usd
CY2023Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
239543 usd
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
15708 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
54000 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
119429 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
385805 usd
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
5916793 usd
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
68800 usd
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
129344 usd
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
129344 usd
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
247680 usd
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
5341625 usd
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
5916793 usd
us-gaap Interest Costs Incurred Capitalized
InterestCostsIncurredCapitalized
135109 usd
CY2023Q1 hcil Numberof Allotted Shares
NumberofAllottedShares
100 shares
CY2023Q1 us-gaap Share Price
SharePrice
1
us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
100 shares
us-gaap Subsidiary Or Equity Method Investee Cumulative Number Of Shares Issued For All Transactions
SubsidiaryOrEquityMethodInvesteeCumulativeNumberOfSharesIssuedForAllTransactions
100 shares
CY2023Q1 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
100 shares
CY2023Q1 hcil Share Capital Issued And Outstanding
ShareCapitalIssuedAndOutstanding
100 shares
CY2023Q1 us-gaap Subsidiary Or Equity Method Investee Cumulative Number Of Shares Issued For All Transactions
SubsidiaryOrEquityMethodInvesteeCumulativeNumberOfSharesIssuedForAllTransactions
100 shares
CY2023Q2 hcil Capital Contribution
CapitalContribution
41241108 usd
CY2023Q3 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
100 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
3435416 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1331757 usd
hcil Refunds From A Related Party
RefundsFromARelatedParty
58469 usd
CY2023Q2 us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
60000000 cny
CY2024Q2 us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
30000000 cny
CY2024Q2 us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
20000000 cny
CY2024Q2 us-gaap Other Commitment
OtherCommitment
17128091 usd
CY2023Q4 us-gaap Other Commitment
OtherCommitment
23698063 usd
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 hcil Advances From Customers
AdvancesFromCustomers
usd
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
usd
CY2023Q2 us-gaap Revenues
Revenues
usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
usd
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
usd
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
415582375 shares
hcil Contribution From Shareholder
ContributionFromShareholder
usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
hcil Accrued Interest Income Derived From Loan To Third Party
AccruedInterestIncomeDerivedFromLoanToThirdParty
usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
usd
us-gaap Increase Decrease In Prepaid Supplies
IncreaseDecreaseInPrepaidSupplies
usd
hcil Increase Decrease Advance From Customer
IncreaseDecreaseAdvanceFromCustomer
usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
usd
hcil Increase Decrease Deferred Subsidies
IncreaseDecreaseDeferredSubsidies
usd
us-gaap Proceeds From Payments For Long Term Loans For Related Parties
ProceedsFromPaymentsForLongTermLoansForRelatedParties
usd
hcil Repayments From A Third Party Investing
RepaymentsFromAThirdPartyInvesting
usd
hcil Payments Of Loan To Third Party
PaymentsOfLoanToThirdParty
usd
us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
usd
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
usd
us-gaap Interest Paid
InterestPaid
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
hcil Increased Accounts Payableconstruction In Progress For Constructioninprogress
IncreasedAccountsPayableconstructionInProgressForConstructioninprogress
usd
us-gaap Interest Paid Capitalized
InterestPaidCapitalized
usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
usd
us-gaap Advertising Expense
AdvertisingExpense
usd
us-gaap Advertising Expense
AdvertisingExpense
usd
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
usd
CY2024Q2 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
usd
CY2024Q2 us-gaap Allowance For Doubtful Other Receivables Current
AllowanceForDoubtfulOtherReceivablesCurrent
usd
CY2023Q2 us-gaap Allowance For Doubtful Other Receivables Current
AllowanceForDoubtfulOtherReceivablesCurrent
usd
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
usd
CY2024Q2 us-gaap Inventory Adjustments
InventoryAdjustments
usd
CY2023Q4 us-gaap Inventory Adjustments
InventoryAdjustments
usd
CY2024Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
usd
CY2024Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
usd
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
usd
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
usd
CY2023Q4 hcil Advance Payment For Equipment
AdvancePaymentForEquipment
usd
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
usd
us-gaap Interest Costs Incurred Capitalized
InterestCostsIncurredCapitalized
usd
CY2023Q2 us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
8500000 usd
CY2024Q2 us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
4100000 usd
CY2024Q2 us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
2800000 usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001086303

Files In Submission

Name View Source Status
0001213900-24-068246-index-headers.html Edgar Link pending
0001213900-24-068246-index.html Edgar Link pending
0001213900-24-068246.txt Edgar Link pending
0001213900-24-068246-xbrl.zip Edgar Link pending
ea0210084-10q_hongchang.htm Edgar Link pending
ea021008401ex31-1_hongchang.htm Edgar Link pending
ea021008401ex31-2_hongchang.htm Edgar Link pending
ea021008401ex32-1_hongchang.htm Edgar Link pending
ea021008401ex32-2_hongchang.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
hcil-20240630.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
hcil-20240630_cal.xml Edgar Link unprocessable
hcil-20240630_def.xml Edgar Link unprocessable
hcil-20240630_lab.xml Edgar Link unprocessable
hcil-20240630_pre.xml Edgar Link unprocessable
ea0210084-10q_hongchang_htm.xml Edgar Link completed
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable